The trademark application c-srRNA was filed by Elixirgen Therapeutics, Inc, a U.S. corporation (the "Applicant"). The application was published for oppositions on February 27, 2022, and it was registered by office on June 6, 2022 without any oppositions.
The application was filed in Dutch (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on September 18, 2023.